American Society of Clinical Oncology statement: A conceptual framework to assess the value of cancer treatment options Journal Article


Authors: Schnipper, L. E.; Davidson, N. E.; Wollins, D. S.; Tyne, C.; Blayney, D. W.; Blum, D.; Dicker, A. P.; Ganz, P. A.; Hoverman, J. R.; Langdon, R.; Lyman, G. H.; Meropol, N. J.; Mulvey, T.; Newcomer, L.; Peppercorn, J.; Polite, B.; Raghavan, D.; Rossi, G.; Saltz, L.; Schrag, D.; Smith, T. J.; Yu, P. P.; Hudis, C. A.; Schilsky, R. L.
Article Title: American Society of Clinical Oncology statement: A conceptual framework to assess the value of cancer treatment options
Keywords: prednisone; chemotherapy; prostate-cancer; cell lung-cancer; multiple-myeloma; care; her2-positive breast-cancer; open-label; increased survival; top 5 list; plus adjuvant
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 23
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-08-10
Start Page: 2563
End Page: 2577
Language: English
ACCESSION: WOS:000361654600013
DOI: 10.1200/jco.2015.61.6706
PROVIDER: wos
PUBMED: 26101248
PMCID: PMC5015427
Notes: Article -- Source: Wos
Altmetric Score
MSK Authors
  1. Clifford Hudis
    840 Hudis
  2. Leonard B Saltz
    580 Saltz